Headlands Technologies LLC Fulgent Genetics, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$19.09 - $22.57 $954 - $1,128	50 New	50 $0
Q4 2023 Feb 02, 2024	SELL	$23.64 - $30.27 $8,203 - $10,503	-347 Reduced 85.26%	60 $1,000
Q3 2023 Nov 09, 2023	SELL	$26.74 - $40.81 $40,992 - $62,561	-1,533 Reduced 79.02%	407 $10,000
Q2 2023 Aug 03, 2023	BUY	$28.52 - $40.7 $55,328 - $78,958	1,940 New	1,940 $71,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.